Extrahepatic spread of hepatocellular carcinoma (HCC) diagnosed during the clinical course of the disease is not frequent; however, with the prolonged survival of HCC patients, the incidence of extrahepatic metastases seems to be increasing.
Methods and study design
We present four unusual cases of extrahepatic metastasis from HCC: the first concerns a patient who underwent a liver transplantation for HCC with cirrhosis and three years later developed metastases in the lung and the left orbit; the second is that of a patient who developed an extraperitoneal pararectal metastasis; in the third case a large osteolytic lesion developed on the left iliac bone, and in the fourth case we found an isolated metastasis in the left mandible.
Results and conclusions
These cases offer important information related to the unusual biology of isolated metastases from HCC after successful treatment of the primary cancer.
ParkinD.M., BrayF., FerlayJ., PisaniP.: Global cancer statistics, 2002.CA Cancer J Clin, 55: 74–108, 2005.
2.
CuradoM.P., EdwardsB., ShinH.R., StormH., FerlayJ., HeanueM., BoyleP. (Eds): Cancer incidence in five continents, Vol. IX. IARC Scientific Publications, No. 160, IARC, Lyon, France, 2007.
3.
IkedaK., SaitohS., TsubotaA., AraseY., ChayamaK., KumadaH., WatanabeG., TsurumaruM.: Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma.Cancer, 71: 19–25, 1993.
4.
KoikeY., ShiratoriY., SatoS., ObiS., TerataniT., ImamuraM., HamamuraK., ImaiY., YoshidaH., ShiinaS., OmataM.: Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus–an analysis of 236 consecutive patients with a single lesion.Hepatology, 32: 1216–1223, 2000.
5.
EdmondsonH.A., SteinerP.E.: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.Cancer, 7: 462–503, 1954.
6.
AramakiM., KawanoK., KaiT., YokoyamaH., MoriiY., SasakiA., YoshidaT., KitanoS.: Treatment for extrahepatic metastases of hepatocellular carcinoma following successful hepatic resection.Hepatogastroenterology, 46: 2931–2934, 1999.
7.
HanazakiK., KajikawaS., KoideN., AdachiW., AmanoJ.: Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis.Am J Gastroenterol, 96: 1243–1250, 2001.
8.
KimB.K., HanK.H., ParkY.N., ParkM.S., KimK.S., ChoiJ.S., MoonB.S., ChonC.Y., MoonY.M., AhnS.H.: Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.J Surg Oncol, 97: 246–252, 2008.
KojiroM., SugiharaS., KakizoeS., NakashimaO., KiyomatsuK.: Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy.Cancer Chemother Pharmacol, 23(Suppl): S4–8, 1989.
22.
HwangS., LeeS.G., LeeY.J., AhnC.S., KimK.H., ParkK.M., MoonK.M., MoonD.B., HaT.Y., YuE.S., ChoiG.W.: Prognostic impact of sarcomatous change of hepatocellular carcinoma in patients undergoing liver resection and liver transplantation.J Gastrointest Surg, 12: 718–724, 2008.
23.
KakizoeS., KojiroM., NakashimaT.: Hepatocellular carcinoma with sarcomatous change. Clinicopathologic and immunohistochemical studies of 14 autopsy cases.Cancer, 59: 310–316, 1987.
24.
KooH.R., ParkM.S., KimM.J., LimJ.S., YuJ.S., JinH., KimK.W.: Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases.J Comput Assist Tomogr, 32: 745–749, 2008.
